As of 2024-09-11, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 23.7x | 18.7x |
| Forward P/E multiples | 20.3x - 25.1x | 23.8x |
| Fair Price | (29.91) - (35.21) | (31.37) |
| Upside | -178.2% - -192.1% | -182.1% |
| Date | EV/EBITDA |